Chronic Immunosuppression and Potential Infection Risks in CSF1R ‐Related Leukoencephalopathy-Reference-Cited by-同舟云学术

Chronic Immunosuppression and Potential Infection Risks in CSF1R ‐Related Leukoencephalopathy

Published:2021-06 Issue:6 Volume:36 Page:1470-1471
ISSN:0885-3185
Container-title:Movement Disorders
language:en
Short-container-title:Mov Disord

Author:

Han Jinming¹^ORCID,Harris Robert A.¹,Karrenbauer Virginija Danylaité²³^ORCID

Affiliation:

1. Applied Immunology and Immunotherapy, Department of Clinical Neuroscience, Karolinska Institutet, Center for Molecular Medicine Karolinska University Hospital Solna Sweden

2. Neuroepidemiology with focus on MS, Department of Clinical Neuroscience Karolinska Institutet Stockholm Sweden

3. Medical Unit Neurology Karolinska University Hospital Stockholm Sweden

Publisher

Wiley

Subject

Neurology (clinical),Neurology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/mds.28627

Reference7 articles.

1. Is Pre‐Symptomatic Immunosuppression Protective in CSF1R ‐ Related Leukoencephalopathy?

2. Microglial replacement therapy: a potential therapeutic strategy for incurable CSF1R-related leukoencephalopathy

3. Characteristic microglial features in patients with hereditary diffuse leukoencephalopathy with spheroids

4. Microglia are required for protection against lethal coronavirus encephalitis in mice

5. Infection Risks Among Patients With Multiple Sclerosis Treated With Fingolimod, Natalizumab, Rituximab, and Injectable Therapies

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Inhibition of colony stimulating factor-1 receptor (CSF-1R) as a potential therapeutic strategy for neurodegenerative diseases: opportunities and challenges;Cellular and Molecular Life Sciences;2022-04

2. Neuropathological Findings of CSF1R ‐Related Leukoencephalopathy After Long‐Term Immunosuppressive Therapy;Movement Disorders;2022-01-19

3. Neuroimaging phenotypes of CSF1R ‐related leukoencephalopathy: Systematic review, meta‐analysis, and imaging recommendations;Journal of Internal Medicine;2021-12-22